SPRO
Spero Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.21
−0.82%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -1.10x
- Debt / assets
- 0.04x
- Debt / EBITDA
- 0.27x
- Net debt / EBITDA
- -6.33x
Liquidity & coverage
- Current ratio
- 6.12x
- Quick ratio
- 6.12x
- Cash ratio
- 6.02x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $43.2M
Cash & dividend
- FCF / debt
- 9.58x
- Cash flow / debt
- 9.58x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026